MOMETASONE FUROATE solution United States - English - NLM (National Library of Medicine)

mometasone furoate solution

cosette pharmaceuticals, inc. - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - mometasone furoate 1 mg in 1 ml - mometasone furoate topical solution usp, 0.1% (lotion) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years of age or older. mometasone furoate topical solution usp, 0.1% (lotion) is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparation. teratogenic effects pregnancy category c: there are no adequate and well-controlled studies in pregnant women. therefore, mometasone furoate topical solution usp, 0.1% (lotion) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. when administered to pregnant rats, rabbits, and

MOMETASONE FUROATE- mometasone furoate spray, metered United States - English - NLM (National Library of Medicine)

mometasone furoate- mometasone furoate spray, metered

remedyrepack inc. - mometasone (unii: 8hr4qj6dw8) (mometasone - unii:8hr4qj6dw8) - mometasone 50 ug - mometasone furoate nasal spray 50 mcg is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis, in adults and pediatric patients 2 years of age and older. mometasone furoate nasal spray 50 mcg is indicated for the relief of nasal congestion associated with seasonal allergic rhinitis, in adults and pediatric patients 2 years of age and older. mometasone furoate nasal spray 50 mcg is indicated for the prophylaxis of the nasal symptoms of seasonal allergic rhinitis in adult and adolescent patients 12 years and older. mometasone furoate nasal spray 50 mcg is indicated for the treatment of nasal polyps in patients 18 years of age and older. mometasone furoate nasal spray is contraindicated in patients with known hypersensitivity to mometasone furoate or any of its ingredients. teratogenic effects: pregnancy category c: there are no adequate and well-controlled studies in pregnant women. mometasone furoate nasal spray 50 mcg, like other corticosteroids, should be

MOMETASONE FUROATE solution United States - English - NLM (National Library of Medicine)

mometasone furoate solution

e. fougera & co. a division of fougera pharmaceuticals inc. - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - mometasone furoate 1 mg in 1 ml - mometasone furoate lotion (mometasone furoate topical solution 0.1%) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years of age or older. mometasone furoate lotion (mometasone furoate topical solution 0.1%) is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparation. teratogenic effects, pregnancy category c: there are no adequate and well-controlled studies in pregnant women. therefore, mometasone furoate lotion (mometasone furoate topical solution 0.1%) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. when administered to pregnant rats, rabbits, and mice, mometas

mometasone furoate- mometasone furoate lotion United States - English - NLM (National Library of Medicine)

mometasone furoate- mometasone furoate lotion

warrick pharmaceuticals corporation - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - lotion - 1 mg in 1 ml - mometasone furoate lotion 0.1% (mometasone furoate topical solution usp) is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. since safety and efficacy of mometasone furoate lotion 0.1% have not been established in pediatric patients below 12 years of age, its use in this age group is not recommended, (see precautions – pediatric use ). mometasone furoate lotion 0.1% (mometasone furoate topical solution usp) is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparation.

MOMETASONE FUROATE ointment United States - English - NLM (National Library of Medicine)

mometasone furoate ointment

torrent pharmaceuticals limited - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - mometasone furoate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 2 years of age or older.           mometasone furoate ointment is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparation. teratogenic effects pregnancy category c: there are no adequate and well-controlled studies in pregnant women. therefore, mometasone furoate ointment should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. when administered to pregnant rats, rabbits, and mice, mometasone furoate increased fetal malformations. the doses that produced malformations also decreased fetal growth, a

Mometasone furoate 50 micrograms/actuation nasal spray, suspension Malta - English - Medicines Authority

mometasone furoate 50 micrograms/actuation nasal spray, suspension

cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - mometasone furoate - nasal spray, suspension - mometasone furoate 50 µg - nasal preparations

Mometasone 0.1% cream United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mometasone 0.1% cream

glenmark pharmaceuticals europe ltd - mometasone furoate - cutaneous cream - 1mg/1gram

Mometasone Furoate Cream 1mg/g Malta - English - Medicines Authority

mometasone furoate cream 1mg/g

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - mometasone furoate - cream - mometasone furoate 0.1 % (w/w) - corticosteroids, dermatological preparations

Mometasone Furoate Cream 0.1%w/w Malta - English - Medicines Authority

mometasone furoate cream 0.1%w/w

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - mometasone furoate - cream - mometasone furoate 0.1 % (w/w) - corticosteroids, dermatological preparations

Mometasone Furoate Ointment 0.1%w/w Malta - English - Medicines Authority

mometasone furoate ointment 0.1%w/w

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - mometasone furoate - ointment - mometasone furoate 0.1 % (w/w) - corticosteroids, dermatological preparations